FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308771505> ?p ?o ?g. }

• W4308771505 abstract "Abstract Background The improved survival rate for many cancers in high-income countries demands a coordinated multidisciplinary approach to survivorship care and service provision to ensure optimal patient outcomes and quality of life. This study assesses the feasibility of introducing a Women’s Health Initiative cancer survivorship clinic in Ireland. Methods The trial comprises an intervention and control arm. Two hundred participants will be recruited. Key eligibility (1) women with early-stage hormone receptor-positive breast or gynecologic cancer (cervix or endometrial), within 12 months of completion of primary curative therapy, and (2) access to the Internet. The complex intervention comprises a nurse-led clinic targeting symptom management through a trigger alert system, utilizing electronic patient-reported outcome (ePRO) assessments at baseline, and 2, 4, 6, 8, 10, and 12 months. It also includes input from a dietitian monitoring diet and nutritional status. The control group will receive their usual care pathway standard of care and attend the cancer survivorship clinic and complete ePRO assessments at the start and end of the study. The primary endpoint (feasibility) includes the proportion of enrolled participants who complete baseline and follow-up ePRO surveys and partake in health professional consultations after ePRO data triggers. Secondary endpoints include changes in cancer-related symptom scores assessed by ePROs, health-related Quality of Life Questionnaire (QLQ) scores, Appraisal Self-Care Agency-R scores, and adjuvant endocrine therapy medication adherence. A process evaluation will capture the experiences of participation in the study, and the healthcare costs will be examined as part of the economic analysis. Ethical approval was granted in December 2020, with accrual commencing in March 2021. Discussion This protocol describes the implementation of a parallel arm randomized controlled trial (RCT) which examines the feasibility of delivering a Cancer Survivorship Clinic. The ePRO is an innovative symptom monitoring system which detects the treatment-related effects and provides individualized support for cancer survivors. The findings will provide direction for the implementation of future survivorship care. Trial registration ClinicalTrials.gov , NCT05035173 . Retrospectively registered on September 5, 2021" @default.
• W4308771505 created "2022-11-15" @default.
• W4308771505 creator A5002683562 @default.
• W4308771505 creator A5004542056 @default.
• W4308771505 creator A5009107767 @default.
• W4308771505 creator A5013456124 @default.
• W4308771505 creator A5018389199 @default.
• W4308771505 creator A5021528482 @default.
• W4308771505 creator A5025694536 @default.
• W4308771505 creator A5029559816 @default.
• W4308771505 creator A5030012957 @default.
• W4308771505 creator A5030815865 @default.
• W4308771505 creator A5032172341 @default.
• W4308771505 creator A5034092438 @default.
• W4308771505 creator A5037855405 @default.
• W4308771505 creator A5038061014 @default.
• W4308771505 creator A5039124404 @default.
• W4308771505 creator A5052283794 @default.
• W4308771505 creator A5060391756 @default.
• W4308771505 creator A5068549355 @default.
• W4308771505 creator A5072064814 @default.
• W4308771505 creator A5089722547 @default.
• W4308771505 date "2022-11-10" @default.
• W4308771505 modified "2023-10-06" @default.
• W4308771505 title "The Women’s Health Initiative cancer survivorship clinic incorporating electronic patient-reported outcomes: a study protocol for the Linking You to Support and Advice (LYSA) randomized controlled trial" @default.
• W4308771505 cites W1491802571 @default.
• W4308771505 cites W1539925347 @default.
• W4308771505 cites W1553392388 @default.
• W4308771505 cites W1763526952 @default.
• W4308771505 cites W1765901980 @default.
• W4308771505 cites W1842259040 @default.
• W4308771505 cites W1883569704 @default.
• W4308771505 cites W1983718152 @default.
• W4308771505 cites W1985816353 @default.
• W4308771505 cites W2021466689 @default.
• W4308771505 cites W2024353853 @default.
• W4308771505 cites W2065491381 @default.
• W4308771505 cites W2076682535 @default.
• W4308771505 cites W2086090717 @default.
• W4308771505 cites W2094072338 @default.
• W4308771505 cites W2103080374 @default.
• W4308771505 cites W2106726191 @default.
• W4308771505 cites W2113357548 @default.
• W4308771505 cites W2137904825 @default.
• W4308771505 cites W2137955525 @default.
• W4308771505 cites W2142960568 @default.
• W4308771505 cites W2155640445 @default.
• W4308771505 cites W2162420979 @default.
• W4308771505 cites W2166236605 @default.
• W4308771505 cites W2167571044 @default.
• W4308771505 cites W2170036462 @default.
• W4308771505 cites W2214671793 @default.
• W4308771505 cites W2238083898 @default.
• W4308771505 cites W2268070902 @default.
• W4308771505 cites W2318545861 @default.
• W4308771505 cites W2519955855 @default.
• W4308771505 cites W2612911641 @default.
• W4308771505 cites W2620925856 @default.
• W4308771505 cites W2794316606 @default.
• W4308771505 cites W2801551758 @default.
• W4308771505 cites W2883512800 @default.
• W4308771505 cites W2890406258 @default.
• W4308771505 cites W2902918430 @default.
• W4308771505 cites W2904527895 @default.
• W4308771505 cites W2913073318 @default.
• W4308771505 cites W2960594563 @default.
• W4308771505 cites W2995262797 @default.
• W4308771505 cites W3000140038 @default.
• W4308771505 cites W3021215541 @default.
• W4308771505 cites W3130550224 @default.
• W4308771505 cites W3138317816 @default.
• W4308771505 cites W3162993738 @default.
• W4308771505 cites W4246212908 @default.
• W4308771505 doi "https://doi.org/10.1186/s40814-022-01186-x" @default.
• W4308771505 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36357934" @default.
• W4308771505 hasPublicationYear "2022" @default.
• W4308771505 type Work @default.
• W4308771505 citedByCount "1" @default.
• W4308771505 countsByYear W43087715052022 @default.
• W4308771505 crossrefType "journal-article" @default.
• W4308771505 hasAuthorship W4308771505A5002683562 @default.
• W4308771505 hasAuthorship W4308771505A5004542056 @default.
• W4308771505 hasAuthorship W4308771505A5009107767 @default.
• W4308771505 hasAuthorship W4308771505A5013456124 @default.
• W4308771505 hasAuthorship W4308771505A5018389199 @default.
• W4308771505 hasAuthorship W4308771505A5021528482 @default.
• W4308771505 hasAuthorship W4308771505A5025694536 @default.
• W4308771505 hasAuthorship W4308771505A5029559816 @default.
• W4308771505 hasAuthorship W4308771505A5030012957 @default.
• W4308771505 hasAuthorship W4308771505A5030815865 @default.
• W4308771505 hasAuthorship W4308771505A5032172341 @default.
• W4308771505 hasAuthorship W4308771505A5034092438 @default.
• W4308771505 hasAuthorship W4308771505A5037855405 @default.
• W4308771505 hasAuthorship W4308771505A5038061014 @default.
• W4308771505 hasAuthorship W4308771505A5039124404 @default.
• W4308771505 hasAuthorship W4308771505A5052283794 @default.
• W4308771505 hasAuthorship W4308771505A5060391756 @default.
• W4308771505 hasAuthorship W4308771505A5068549355 @default.
• W4308771505 hasAuthorship W4308771505A5072064814 @default.
• W4308771505 hasAuthorship W4308771505A5089722547 @default.

• next